Molecular prognostic factors in patients with pancreatic cancer

Author： Tonini Giuseppe   Pantano Francesco   Vincenzi Bruno   Gabbrielli Armando   Coppola Roberto   Santini Daniele  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.11, Iss.12, 2007-12, pp. : 1553-1569

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular and Genetic Bases of Pancreatic Cancer

By  

Current Drug Targets, Vol. 13, Iss. 6, 2012-05 ,pp. : 731-743

Bentham Science Publishers

Access to resources Recommend Favorite

Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer

By  

Current Pharmaceutical Design, Vol. 22, Iss. 42, 2017-01 ,pp. : 6444-6450

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Targeted Approaches for Treatment of Pancreatic Cancer

By  

Current Pharmaceutical Design, Vol. 17, Iss. 21, 2011-07 ,pp. : 2221-2238

Bentham Science Publishers

Access to resources Recommend Favorite

VEGF pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a 2013 update

By Eng Lawson   Liu Geoffrey  

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1659-1667

Future Medicine

Access to resources Recommend Favorite

Base Excision Repair Factors are Promising Prognostic and Predictive Markers in Cancer

By  

Current Molecular Pharmacology, Vol. 5, Iss. 1, 2012-01 ,pp. : 115-124

Bentham Science Publishers

Access to resources Recommend Favorite